Breast Cancer

Across the seven major markets (US, Japan, UK, Germany, Italy, France, Spain), approximately 450,000 women were estimated to have developed breast cancer with more than 100,000 dying from the disease. It is the leading cause of gynecological cancer-related death among women, yet relative to other cancers features one of the lowest mortality rates across the seven major pharmaceutical markets.

Our vaccine

MVA-BN® HER2 
Therapeutic breast cancer vaccine, Phase I/II